RxDoctor Payments Data

Makayla Kiser, DO

Family Medicine · Georgetown, KYNPI 1023456878

Payments from drug & device makers

$8,587in general payments, 2019–2025

Across 532 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • GSK$794
  • Pfizer$564
  • Lilly USA, LLC$532
  • AstraZeneca$508
  • plus $4K from 45 others

What the payments were for

  • Food & beverage$8,581100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,587 in reported general payments places this provider in the 90th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,346
Medicare patients
59
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$59,933
JanuviaSitagliptin Phosphate40$38,793
RybelsusSemaglutide20$29,527
JardianceEmpagliflozin22$22,691
EliquisApixaban18$21,797
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$21,392
XareltoRivaroxaban17$19,270
JanumetSitagliptin Phos/Metformin Hcl16$13,876
FarxigaDapagliflozin Propanediol22$12,430
Combivent RespimatIpratropium/Albuterol Sulfate14$6,748
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$5,529
Fentanyl25$4,809
Albuterol Sulfate HfaAlbuterol Sulfate127$3,014
SynthroidLevothyroxine Sodium43$2,695
Levothyroxine Sodium228$2,503

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,046$89,46069 claims
MerckJanuvia, Janumet$129$52,66956 claims
Boehringer IngelheimJardiance, Combivent Respimat$398$29,43936 claims
PfizerEliquis$564$21,79718 claims
GSKTrelegy Ellipta$794$21,39220 claims
Johnson & JohnsonXarelto$204$19,27017 claims
AstraZenecaFarxiga$508$12,43022 claims
AbbVieSynthroid$1,157$2,69543 claims
Almatica Pharma LLCSertraline Hcl$40$69993 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Georgetown

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →